Show simple item record

dc.contributor.authorvan As, Nicholas
dc.contributor.authorGriffin, Clare
dc.contributor.authorTree, Alison
dc.contributor.authorPatel, Jaymini
dc.contributor.authorOstler, Peter
dc.contributor.authorvan der Voet, Hans
dc.contributor.authorLoblaw, Andrew
dc.contributor.authorChu, William
dc.contributor.authorFord, Daniel
dc.contributor.authorTolan, Shaun
dc.contributor.authorJain, Suneil
dc.contributor.authorCamilleri, Philip
dc.contributor.authorKancherla, Kiran
dc.contributor.authorFrew, John
dc.contributor.authorChan, Andrew
dc.contributor.authorNaismith, Olivia
dc.contributor.authorArmstrong, John
dc.contributor.authorStaffurth, John
dc.contributor.authorMartin, Alexander
dc.contributor.authorDayes, Ian
dc.contributor.authorWells, Paula
dc.contributor.authorPrice, Derek
dc.contributor.authorWilliamson, Emily
dc.contributor.authorPugh, Julia
dc.contributor.authorManning, Georgina
dc.contributor.authorBrown, Stephanie
dc.contributor.authorBurnett, Stephanie
dc.contributor.authorHall, Emma
dc.date.accessioned2024-11-11T14:16:06Z
dc.date.available2024-11-11T14:16:06Z
dc.date.issued2024
dc.identifier.citationN. van As, C. Griffin, A. Tree, J. Patel, P. Ostler, H. van der Voet, A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, J. Armstrong, J. Staffurth, A. Martin, I. Dayes, P. Wells, D. Price, E. Williamson, J. Pugh, G. Manning, S. Brown, S. Burnett, and E. Hallen_US
dc.identifier.eissn1533-4406
dc.identifier.doi10.1056/NEJMoa2403365
dc.identifier.pmid39413377
dc.identifier.urihttp://hdl.handle.net/20.500.14200/6469
dc.description.abstractWhether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized prostate cancer is unclear.en_US
dc.language.isoenen_US
dc.publisherMassachusetts Medical Societyen_US
dc.relation.urlDOI: 10.1056/NEJMoa2403365en_US
dc.rightsCopyright © 2024 Massachusetts Medical Society.
dc.titlePhase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.en_US
dc.typeArticleen_US
dc.typeOtheren_US
dc.source.journaltitleThe New England Journal of Medicineen_US
dc.source.volume391
dc.source.issue15
dc.source.beginpage1413
dc.source.endpage1425
dc.source.countryUnited Kingdom
dc.source.countryUnited Kingdom
dc.source.countryUnited States
rioxxterms.versionAOen_US
dc.contributor.trustauthorFord, Daniel
dc.contributor.departmentOncology
dc.contributor.roleMedical and Dentalen_US
dc.date.accepted2024
dc.identifier.journalThe New England journal of medicine
oa.grant.openaccessyesen_US


This item appears in the following Collection(s)

Show simple item record